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Abstract The expression and localization of the helix-loop-
helix transcription factors Id1 and Id3, as well as localization of
the E12-protein, were studied in cells isolated from human
articular cartilage and chondrosarcoma. Serum withdrawal
down-regulated Id1 and Id3 expression in chondrocytes but not
the Id1 expression in chondrosarcoma cells. Antisense oligonu-
cleotides directed against Id1 and Id3 decreased BrdU labeling in
both cell types. E12 was localized to the nucleus in chondrocytes
and non-confluent tumor cells and in confluent tumor cells, E12
had a cytoplasmic localization. This study suggests a functional
role for Id1 and Id3 in the control of proliferation and
differentiation of cartilage.
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1. Introduction
Cell di¡erentiation is related to a decrease in cell prolifer-
ation in normal tissues but in tumor cells, loss of di¡erenti-
ated features is combined with uncontrolled proliferation.
However, the links between these two events in tumors are
unknown, as are most of the events leading to di¡erentiation
in normal tissues. The transcription factors family of helix-
loop-helix (HLH) proteins has been found to be important for
cellular di¡erentiation and thus involved in the developmental
control of gene expression. The proteins are divided into dif-
ferent classes; class A consists of the ubiquitously expressed
E-proteins, E12 and E47, which are alternately spliced prod-
ucts from the E2A gene [1]. These proteins form heterodimers
with the tissue restricted class B proteins, e.g. MyoD in
muscle [2]. The heterodimer is formed through the HLH do-
main of the proteins and the complex is then capable of bind-
ing to a speci¢c enhancer element in the DNA, known as the
E-box consensus sequence (CANNTG). The basic amino acid
region next to the HLH motif mediates the DNA binding.
Another member of the HLH family is a group of proteins
called Id (inhibitor of di¡erentiation/DNA binding). These
proteins lack the basic amino acid domain. Thus, hetero-
dimers formed by Id and basic HLH proteins will be inactive
and no transcriptional activation will appear [3]. Today, there
are four known human Id proteins: Id1 [4], Id2 [5], Id3 [6,7]
and Id4 [8]. These proteins have highly homologous HLH
domains, but homology is low outside this region. For the
Id1 gene, an alternative splicing form has been demonstrated
in both mouse and human [9^11]. However, the functional
role of this non-spliced gene product is still unknown. The
wide expression of especially Id1 and Id3 in di¡erent cell types
suggests an important role and it has been proposed that Id
proteins function as general inhibitors of terminal di¡erentia-
tion and thus in control of cell growth. These ideas are sup-
ported by the ¢nding that the Id coding genes are expressed in
di¡erent kinds of tumor cells [6,11,12].
One tissue where di¡erentiation control of HLH proteins
has been extensively studied is in muscle development where
the proteins have been held responsible for the muscle-speci¢c
di¡erentiation from mesenchymal stem cells [2]. The di¡eren-
tiating pathway in cartilage, another tissue of mesenchymal
origin, is still unclear. In addition, little is known about the
factors and events leading to the formation of chondrosarco-
ma, a malignant chondrogenic tumor. In an attempt to better
understand the molecular interactions between di¡erentiation,
dedi¡erentiation and proliferation in cartilaginous tissue, we
have focused on Id1 and Id3 and investigated their expression,
at both genetic and protein level, and their protein localiza-
tion. The functional role of Id1 and Id3 in cultured human
articular chondrocytes and in chondrosarcoma cells has been
studied with antisense experiments. In addition, one E-protein
was also included in this study in order to give a somewhat
extended picture of the function of the Ids. Therefore, the
cellular localization of E12 was investigated in cultured cells.
2. Materials and methods
2.1. Cell culture
Tumor cells were obtained from 9 cases of chondrosarcoma of
di¡erent histological grades. There were one grade I^II (K12), four
grade II (K5, K6, K8, K9), two grade II^III (K1, K2) and two grade
III (K7, K11). K5 and K6 correspond to the cell lines FS090 and
105KC, respectively, both kindly donated by Dr. J. Block. The re-
maining cell cultures were generated from tumors surgically excised at
the Department of Orthopedics, Sahlgrenska University Hospital,
Gothenburg, Sweden. In addition, articular chondrocytes (TC) from
one of the tumor patients as well as articular chondrocytes (C1^C13)
obtained during cartilage transplantation from a total of 13 other
patients free from tumors were cultured and analyzed in the same
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way. Monolayer cultured cells were grown in Dulbecco’s MEM Nut
Mix F-12 (Life Technologies, Paysley, Scotland, UK) supplemented
with amphotericin B (2 Wg/ml), gentamycin sulfate (50 Wg/ml), L-as-
corbic acid (50 Wg/ml) and L-glutamine (2 mM). To this medium 10%
fetal calf serum (FCS, Harlan Sera-Lab, Crawley Down, UK) and 1%
Ultroser (Life Technologies) was added. This medium is referred to in
the text as serum containing medium. Prior to RNA or protein ex-
traction, cells were trypsinized and rinsed in phosphate-bu¡ered saline
(PBS, 0.01 M, pH 7.5). In a ¢rst series of experiments, cells were
cultured to con£uence at serum levels as described. In a second round
of experiments, cells from a smaller group of the patients in the study
were grown to con£uence and then starved by complete serum with-
drawal for 24 h before harvesting.
2.2. RNase protection assay
Total cellular RNA was prepared using the RNeasy total RNA kit
(Qiagen, Hilden, Germany) according to the manufacturer’s instruc-
tions. Using RT-PCR and subsequent cloning into PCRII vectors
(Invitrogen, Leek, the Netherlands), riboprobes of 298 bp, 245 bp
and 354 bp for human Id1, Id1.25 and Id3, respectively, were gener-
ated. The probes were used in the ribonuclease protection assay
(RPA) with the RPAII-kit (Ambion, Austin, TX, USA). Brie£y, total
RNA (7 Wg) from cultured articular chondrocytes and chondrosarco-
ma cells was hybridized overnight at 45‡C with [Q-33P]dUTP (Dupont
NEN, Bad Homburg, Germany) labeled Id1 and Id3 probes or the
Id1.25 probe. RNase digestion was carried out at 37‡C for 30 min. As
a negative control, the probe was hybridized with 7 Wg yeast tRNA.
33P-labeled HaeIII DNA (Promega, Madison, WI, USA) was used as
a molecular size marker.
The RNase protected fragments were separated by electrophoresis
through a 6% polyacrylamide gel (Novex, San Diego, CA, USA). The
gels were dried and exposed to Phosphor Imager screens. The screens
were developed on a Phosphor Imager (Molecular Dynamics, USA).
2.3. Western blot
Total protein extracts were prepared by sonicating cell pellets in
1 mM dithiothreitol (DTT). The protein concentration was deter-
mined using the Protein assay kit (Bio-Rad, Hercules, CA, USA).
An equal volume protein/DTT and 2U Novex sample bu¡er were
mixed and 20 Wg of proteins were loaded in each lane of a 14%
Tris-glycine gel. The proteins were size-fractionated on the gel and
then electrophoretically transferred onto a nitrocellulose membrane
(Novex). The membrane was blocked overnight in 10% dry milk
and 0.1% Tween 20 in Tris-bu¡ered saline (TBS) and probed with
one of the following polyclonal rabbit antibodies: anti-Id1, anti-Id3
or anti-E12 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), all
diluted 1:250. After washing in 0.5% Tween 20 in TBS (TBS-T) the
membrane was incubated with anti-rabbit Ig, horseradish peroxidase
linked F(abP)2 fragment (Amersham, Buckinghamshire, UK), diluted
1:10 000. The membrane was washed in TBS-T and TBS, and ¢nally
the immunoreactive proteins were visualized with ECL Western blot-
ting detection system (Amersham).
2.4. Immunohistochemistry
Chondrosarcoma cells (K2, K5^K9 and K12) and articular chon-
drocytes (TC, C1, C3, C8^C10) were cultured on Lab-Tek 8 chamber
slides (Nunc, Naperville, IL, USA) at approximately 1U104 cells/
chamber. The cells were grown to con£uence under the same condi-
tions as above. The slides were washed in PBS, ¢xed in cold acetone
for 10 min and stored at 370‡C. Before use the slides were blocked
with 3% FCS (Harlan Sera-Lab) and 3% goat serum (Dako, Glostrup,
Denmark) in PBS. The same primary antibodies as above were used,
diluted 1:50, and incubated overnight at +4‡C. Normal rabbit immu-
noglobulin (Dako) was used as a negative control. The ABC kit
(Vektor Laboratories, Burlingame, CA, USA) were then used accord-
ing to the manufacturer’s instructions, with a biotinylated goat-anti-
rabbit secondary antibody diluted 1:200. The slides were dehydrated
and mounted with Pertex (Histolab Products, Goºteborg, Sweden) and
then examined with a light microscope (Nikon, Japan).
Immunohistochemistry was also performed on frozen sections of
one of the tumor tissues (K8). This was done in order to control
that all three kinds of proteins were expressed in vivo as well as in
cultured cells. Basically the same protocol as above was used, with a
microwave treatment of the section included before the blocking pro-
cedure.
2.5. BrdU-labeling
Articular chondrocytes (C11^C13) and chondrosarcoma cells (K1,
K2, K5 and K12) were cultured on 4-well Nunc Lab-Tek chamber-
slides (Nunc) at approximately 20 000 cells/chamber. The cells were
grown under the same conditions as above. After 24 h, the non-con-
£uent cells were subjected to complete serum withdrawal. Twenty-
three hours later, antisense phosphorothioate oligonucleotides cover-
ing the translation starts of Id1 (5P GCG ACT TTC ATG ATT CTT
GG-3P) or Id3 (5P-CAG CGC CTT CAT GCT GGG GAG-3P) or a
random oligonucleotide were added to the medium at a ¢nal concen-
tration of 100 Wg/ml. After one hour, FCS and Ultroser were added to
the media to the ¢nal concentrations 10% and 1%, respectively. The
cells were then allowed to grow for an additional 24 h before labeling
with 5-bromo-2-deoxy-uridine (BrdU), using the BrdU Labeling and
Detection kit 1 (Boehringer Mannheim, Mannheim, Germany) ac-
cording to the manufacturer’s instructions. A minimum of about
150 cells were counted in each experiment (cells in 10 visual areas
of a chamber) and the values are given as means þ S.E.M. The stat-
istical signi¢cances of di¡erences between means were calculated ac-
cording to Student’s t-test for dependent samples (Statistica for Win-
dows 5.1, Stat Soft, Tulsa, OK, USA).
3. Results
3.1. Id1 and Id3 mRNA and protein expression in articular
chondrocytes and chondrosarcoma cells
A total of 9 chondrosarcoma cell lines, representing di¡er-
ent histological grades, and 11 cultures of normal chondro-
cytes, obtained from patients during cartilage transplantation,
were studied in separate experiments. The cells were either
cultured in serum containing media until con£uence or
starved with complete serum withdrawal 24 h before harvest-
ing. Expression of the Id1 and Id3 genes and proteins were
studied by RPA and Western blot, respectively (Table 1).
In RPA, Id1 and Id1.25 mRNA was protected as a 298-
and a 245-bp band, respectively, and Id3 mRNA as a 354-bp
band. In cultures with serum containing medium, Id1 was
expressed in all cells studied (Fig. 1A). The level of Id1
mRNA expression was substantially higher in chondrosarco-
ma cells compared to normal chondrocytes. However, after
serum withdrawal, Id1 expression was abolished in normal
chondrocytes but was still present in the chondrosarcoma cells
(Fig. 2A). The expression of Id1.25 was only studied in cells
cultured at normal serum level. A band representing Id1.25
was detected in cells from three of the high malignancy grade
chondrosarcomas (K1, K2 and K7) but not in articular chon-
drocytes. Id3 showed a similar mRNA expression in tumor
cells and articular chondrocytes, and the expression was not
dependent on the serum level in the culture media (Figs. 1A
and 2A).
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Table 1
Expression of Id mRNA and protein in cultured cells
RPA Western blot
Id1 Id1.25 Id3 Id1 Id3
Experiment 1
Cells cultured under serum conditions
Tumor 9/9 3/8 9/9 9/9 5/9
Normal 3/4 0/4 4/4 8/8 2/8
Experiment 2
Cells subjected to serum withdrawal
Tumor 5/5 5/5 5/5 0/5
Normal 0/3 3/3 0/5 0/5
Ratios are the number of cell lines expressing mRNA or protein over
the number of cell lines screened.
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Western blot was used to examine the protein expression of
Id1 and Id3. The 16-kDa Id1 protein was generally more
strongly expressed in chondrosarcoma cells than in normal
chondrocytes, when the cells had been cultured in serum con-
taining media until harvesting (Fig. 1B). In most cells, the
expression of mRNA corresponded to the protein level. The
tumor cells K6 and K7, derived from a grade II and a grade
III chondrosarcoma, respectively, both showed a strong ex-
pression of Id1 mRNA, but demonstrated a weak, if any, Id1
protein expression. In addition, an extra band was also visible
slightly above 16 kDa in most cells. This band may represent
the non-spliced, Id1.25 mRNA protein product.
After 24 h serum withdrawal, the protein expression of Id1
was only present in the tumor cell lines (Fig. 2B).
A variation of Id3 protein expression was detected by West-
ern blot in the non-starved cells (Fig. 1C), but after serum
withdrawal, the protein was absent in both normal cells and
tumor cells.
3.2. Cellular localization of Id1, Id3 and E12 proteins in
articular chondrocytes and chondrosarcoma cells
Cells were cultured on chamberslides with serum containing
media until 24 h post con£uence. Immunohistochemistry was
used to study the cellular localization of the Id1, Id3 and E12
proteins. Id1 staining was predominantly cytoplasmic. Id3
staining was both cytoplasmic and nuclear. The E12 protein
showed nuclear staining both in precon£uent and con£uent
cells. In chondrosarcoma cells, on the other hand, the nuclear
staining seen in precon£uent areas was not demonstrated in
con£uent cells (Fig. 3).
Immunohistochemistry on frozen sections of tumor tissue
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Fig. 2. Expression of Id1 and Id3 in cells cultured with complete se-
rum withdrawal 24 h before harvesting. A: RNA expression of Id1
and Id3 shown by RNase protection assay. Lane 1: 18S probe; lane
2: Id1 probe; lane 3: Id3 probe; lane 4: tRNA used as a negative
control; lanes 5^7: articular chondrocyte mRNA from patients TC,
C8 and C9, respectively; lanes 8^12: chondrosarcoma cell mRNA
from patients K2, K5, K8, K12 and K9, respectively; lane 13:
HaeIII DNA size marker. B: Protein expression of Id1, shown by
Western blot. Comparison between articular chondrocytes cultured
with and without serum withdrawal. Lanes with protein from cells
cultured with full serum level are indicated with + and lanes with
proteins from cells that were subjected to 24-h serum withdrawal
before harvesting are indicated by 3. Lanes 1, 2: Chondrosarcoma
cell proteins from patients K7 and K1, respectively; lanes 3^6: ar-
ticular chondrocyte proteins from patients C4, C5, C7 and C6, re-
spectively.
Fig. 1. Expression of Id1 and Id3 in cells cultured in normal serum
level. A: RNA expressions shown by RNase protection assay. The
bands corresponding to Id1 and Id3 are shown by arrows. A probe
hybridizing to 18S was used as an internal control for equal loading
onto the gel. Lane 1: tRNA serving as a negative control; lanes 2^
5, articular chondrocyte mRNAs from patients C1, C2, C3 and TC,
respectively; lanes 6^14: tumor cell mRNAs from patients K9, K8,
K5, K6, K11, K12, K1, K2 and K7, respectively; lane 15: HaeIII
DNA molecular size marker. Western blot was used to study the
protein expression of Id1 (B) and Id3 (C). Lanes 1^4: Articular
chondrocytes from patients C1, C2, C3 and TC, respectively; lanes
5^13: tumor cell proteins from patients K9, K8, K5, K6, K11, K12,
K1, K2 and K7. The expected bands are indicated by arrows.
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showed a weak staining for all three proteins, indicating that
expression is not restricted to cultured cells (data not shown).
3.3. E¡ect of antisense stimulation of Id1 and Id3 in articular
chondrocytes and chondrosarcoma cells
To study the function of Id1 and Id3, a series of antisense
experiments was carried out. To non-con£uent cells cultured
in chamberslides, di¡erent antisense oligonucleotides were
added and the DNA synthesis was determined by BrdU label-
ing. Besides the antisense oligonucleotides of Id1 and Id3, a
random oligonucleotide was also used in order to see that the
addition of oligonucleotides was non-toxic to the cells. Similar
values of BrdU incorporation were obtained with random
oligonucleotides added and without any oligonucleotide at
all. The BrdU labeling was found to be signi¢cantly lower
when Id1 or Id3 antisense oligonucleotides had been added
to the culture medium than when the random oligonucleotide
was added (Fig. 4). In chondrosarcoma cells, the BrdU incor-
poration was reduced from 43% to 39% with Id1 antisense
oligonucleotide and to 26% with Id3 antisense oligonucleo-
tide. In chondrocytes, the reduction was from 39% to 33%
for Id1. After addition of Id3 antisense oligonucleotide to
the articular chondrocytes, as well as to the low-graded chon-
drosarcoma cells (K12), most cell boundaries seemed to be
disrupted and cell counting was impossible.
An additional experiment was also performed on starved
cells. No BrdU incorporation was noted after serum with-
drawal of chondrocytes, while a mean value of 9% labeled
cells was seen among the chondrosarcoma cells.
4. Discussion
This study has been focused on the two HLH transcription
factors Id1 and Id3 since these have a general expression in
di¡erent tissues and have been found in other tissues of mes-
enchymal origin. We wanted to investigate the functional role
for Id1 and Id3 in cartilage and how expression and local-
ization of these transcription factors were a¡ected by di¡erent
grades of di¡erentiation in cartilage. Since it is di⁄cult to
obtain chondrocytes with di¡erent stages of di¡erentiation,
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Fig. 3. Cellular localization of E12 detected by immunohistochemistry. Normal articular chondrocytes from patient C8 are seen in the left pan-
els (A and C) and chondrosarcoma cells from patient K9 are shown to the right (B and D). Sparse tumor cells (B) show nuclear staining as
well as both sparse and con£uent articular chondrocytes (A and C), while cytoplasmic staining and almost no nuclear staining are detected in
con£uent chondrosarcoma cells (D).
Fig. 4. E¡ect of Id1 and Id3 antisense oligonucleotides on cultured
cells. The mean values of % BrdU-labeled cells and the standard er-
ror of the mean (S.E.M.) are shown.
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the chondrosarcoma cells were chosen to represent the less
di¡erentiated stage.
The expression of the Id proteins was examined at the ge-
netic and protein level under di¡erent culture conditions.
After a ¢rst series of experiments with cells cultured under
serum condition, a smaller series of experiments was per-
formed with cells subjected to complete serum withdrawal
for 24 h before harvesting, to see whether the Id pathway
was activated regardless of serum supplementation of the cul-
ture media. In the case of Id1, normal chondrocytes expressed
both mRNA and protein to a varying degree when cultured in
serum containing medium. However, when the cells were sub-
jected to serum withdrawal, mRNA as well as protein were
absent. This ¢nding is consistent with the function of Id as an
inhibitor of di¡erentiation. A lack of di¡erentiation promotes
further dividing, i.e. Id1 directly or indirectly stimulates cell
division. Antisense experiments showed a signi¢cantly lower
cell proliferation when antisense for Id1 was added to either
chondrocytes or chondrosarcoma cells. This shows that Id1
supports a proliferative function also in cells of cartilaginous
origin. When the chondrocytes are starved, components in the
culture media which are a prerequisite for cell division disap-
pear and the cells stop dividing. Thus, Id1 is no longer needed
to stimulate cell division since the basic needs for proliferating
cells are absent. In this manner, serum supplementation stim-
ulates the expression of Id1, either directly through prolifer-
ation or through another mechanism which in turn will lead
to cell division. The tumor cells, on the other hand, expressed
both Id1 mRNA and protein irrespective of serum conditions.
Even if chondrosarcoma generally is a very slowly growing
tumor and often requires high serum levels in the media in
order to speed up growth rate, this tumor has an ability to
express a proliferating factor, which inhibits di¡erentiation
and stimulates cell division, without any serum stimulation
at all. The strong Id1 protein expression even after serum
withdrawal indicates an autocrine or paracrine stimulation
which induces a less di¡erentiated state of the tumor and
indirectly stimulates proliferation. The BrdU-labeling experi-
ments showed that chondrosarcoma cells were able to under-
go cell division even without serum.
Concerning Id3, the protein expression was dependent on
serum in both chondrocytes and chondrosarcoma cells with
no detectable expression after serum withdrawal. Since chon-
drosarcoma cells were shown to divide even without serum,
the Id3 protein expression seem to be in£uenced by factors
other than those required for cell division. However, both
kinds of cells had a weak to moderate expression of Id3
mRNA even after starvation. One interesting observation
was that the Id3 antisense oligonucleotide added to articular
chondrocytes or to low graded chondrosarcoma cells dis-
rupted the cell boundaries due to a general toxic e¡ect or
through induction of apoptosis. Enforced expression of Id3
has been found to induce apoptosis in serum-deprived rat
embryo ¢broblasts [13]. This data together with ours suggests
that the cell needs a balanced expression of Id3 to function
properly. Id3 seems to have a basic function in normal carti-
lage. In highly malignant tumor cells a signi¢cant reduction
was seen in cell proliferation when Id3 antisense was added,
instead of cell destruction. This may indicate that alteration of
a regulatory pathway including Id3 is a late event in cartilage
tumor formation. Studies on NIH 3T3 ¢broblasts have shown
similar results as ours. When the cells were cultured in low
serum levels, mRNA expression of both Id1 and Id3 were
reduced and a similar antisense experiment also showed re-
duced proliferation [14].
Id1.25 was only expressed in a third of the tumor cells at
the mRNA level. At the protein level, however, a double band
around 16 kDa was seen in most cells, both from neoplastic
and normal origin. There is no evidence that the band of
slightly higher molecular weight really represents Id1.25, and
any conclusion regarding the protein expression of this altered
splice form should be drawn with caution. In this study, we
have chosen to simply regard both bands as unspeci¢ed forms
of Id1.
The cellular localization of Id1, Id3 and E12 was evaluated
with immunohistochemistry. Mainly, cytoplasmic staining of
Id1 was seen, while Id3 generally had both cytoplasmic and
nuclear staining.
In the case of E12, nuclear staining was detected in all
normal cells, with the exception of the articular chondrocytes
derived from one of the tumor patients. In these cells, cyto-
plasmic staining was more frequent. One factor worth notic-
ing, however, is the higher age of this patient (60 years) as
compared to the patients C1^C10 (range from 23 to 43 years).
The above results correlate well with previous ¢ndings [15]. In
the chondrosarcoma cells, however, nuclear staining occurred
in pre-con£uent areas, while in con£uent areas cytoplasmic
staining was seen. This observation suggests an explanation
for the continuous proliferation seen in tumor cells. When the
cells are con£uent, their proliferation normally should be in-
hibited. Di¡erentiation, on the other hand, is able to start
when the nuclear E12 binds to DNA. In tumor cells, E12
was absent in the con£uent cell nuclei. This probably will
a¡ect the E12-dependent di¡erentiating pathway which can-
not start. If di¡erentiation signals lead to decreased prolifer-
ation, rather than the opposite, it seems likely that prolifer-
ation will continue as long as E12 is missing in the
nucleus.
In conclusion, members of the helix-loop-helix transcription
factor family seem to be important elements in the delicate
interactions between di¡erentiation and dedi¡erentiation in
cartilaginous tissue. Still, our knowledge is fragmentary of
the regulatory pathway involving the HLH proteins. Our ¢nd-
ings support the theory of an unknown HLH transcription
factor active in cartilage.
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